SELLAS Life Sciences’ GFH009 Demonstrates Cancer Cell Growth Inhibition in Preclinical In Vitro Studies in Solid Cancer and Acute Myeloid Leukemia Cell Lines
– Results Demonstrate Significant Anti-Tumor Effects on All Selected Cell Lines – – In Three…